share_log
Benzinga ·  May 2 07:06
Agios Pharmaceuticals' Cash, Cash Equivalents and Marketable Securities of $714.3M As Of March 31, 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment